98 related articles for article (PubMed ID: 20130452)
1. Cyclin D3-dependent kinases in lymphoma: redundancy and implications for therapy.
Mistrik M; Bartek J
Cell Cycle; 2010 Feb; 9(3):446-7. PubMed ID: 20130452
[No Abstract] [Full Text] [Related]
2. Cyclin D3 is dispensable for human diffuse large B-cell lymphoma survival and growth: evidence for redundancy with cyclin E.
Gumina MR; Xu C; Chiles TC
Cell Cycle; 2010 Feb; 9(4):820-8. PubMed ID: 20107311
[TBL] [Abstract][Full Text] [Related]
3. V3 loop of human immunodeficiency virus type 1 reduces cyclin E expression and induces G1 arrest in interleukin 2-dependent T cells.
Sakaida H; Kawamata S; Hattori T; Uchiyama T
AIDS Res Hum Retroviruses; 1998 Jan; 14(1):31-8. PubMed ID: 9453249
[TBL] [Abstract][Full Text] [Related]
4. Keratin 19 interacts with GSK3β to regulate its nuclear accumulation and degradation of cyclin D3.
Sharma P; Tiufekchiev S; Lising V; Chung SW; Suk JS; Chung BM
Mol Biol Cell; 2021 Nov; 32(21):ar21. PubMed ID: 34406791
[TBL] [Abstract][Full Text] [Related]
5. Cyclins D3 and E go hand in hand with Cdk4/6 in diffuse large B-cell lymphoma.
Gilmore TD; Thompson RC; Faber AC
Cell Cycle; 2010 Feb; 9(3):448-9. PubMed ID: 20130454
[No Abstract] [Full Text] [Related]
6. A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1.
Scaglione-Sewell BA; Bissonnette M; Skarosi S; Abraham C; Brasitus TA
Endocrinology; 2000 Nov; 141(11):3931-9. PubMed ID: 11089522
[TBL] [Abstract][Full Text] [Related]
7. Tunicamycin enhances the anticellular activity of interferon by inhibiting G1/S phase progression in 3T3 cells.
Madhavan S; Singh AK; Maheshawari RK
J Interferon Cytokine Res; 2000 Mar; 20(3):281-90. PubMed ID: 10762075
[TBL] [Abstract][Full Text] [Related]
8. Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1.
Meng LH; Zhang H; Hayward L; Takemura H; Shao RG; Pommier Y
Cancer Res; 2004 Dec; 64(24):9086-92. PubMed ID: 15604277
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery.
Jensen SS; Madsen MW; Lukas J; Binderup L; Bartek J
Mol Endocrinol; 2001 Aug; 15(8):1370-80. PubMed ID: 11463860
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis.
Al-Aynati MM; Radulovich N; Ho J; Tsao MS
Clin Cancer Res; 2004 Oct; 10(19):6598-605. PubMed ID: 15475449
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells.
Wang QM; Jones JB; Studzinski GP
Cancer Res; 1996 Jan; 56(2):264-7. PubMed ID: 8542578
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
14. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts.
Fry DW; Harvey PJ; Keller PR; Elliott WL; Meade M; Trachet E; Albassam M; Zheng X; Leopold WR; Pryer NK; Toogood PL
Mol Cancer Ther; 2004 Nov; 3(11):1427-38. PubMed ID: 15542782
[TBL] [Abstract][Full Text] [Related]
15. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins.
Baghdassarian N; Catallo R; Mahly MA; Ffrench P; Chizat F; Bryon PA; Ffrench M
Exp Cell Res; 1998 May; 240(2):263-73. PubMed ID: 9596999
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
Srethapakdi M; Liu F; Tavorath R; Rosen N
Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
[TBL] [Abstract][Full Text] [Related]
18. AG490 inhibits G1-S traverse in BALB/c-3T3 cells following either mitogenic stimulation or exogenous expression of E2F-1.
Savell J; Ma Y; Morrow KS; Jove R; Olashaw N; Moseley PL; Cress WD; Wharton W
Mol Cancer Ther; 2004 Feb; 3(2):205-13. PubMed ID: 14985461
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation.
Schoecklmann HO; Rupprecht HD; Zauner I; Sterzel RB
Kidney Int; 1997 Apr; 51(4):1228-36. PubMed ID: 9083291
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of G1 phase cyclin dependent kinases by transforming growth factor beta 1.
Reddy KB; Hocevar BA; Howe PH
J Cell Biochem; 1994 Nov; 56(3):418-25. PubMed ID: 7876335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
